Abstract
Chronic kidney disease (CKD) affects up to 10% of the Australian population, with a significant increase in the incidence of end-stage kidney disease (ESKD) in the last 20 years1. Current projections estimate the number of ESKD patients receiving treatment via transplantation or dialysis to rise from approximately 20,000 in 2011 to at least 29,000 in 20201. There is limited data that quantifies the number of ESKD patients with advanced care directives (ACD) despite considerable morbidity and mortality1-2.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
